Stocks and Investing Stocks and Investing
Fri, September 4, 2020
Thu, September 3, 2020
Wed, September 2, 2020
Tue, September 1, 2020
Mon, August 31, 2020
Fri, August 28, 2020
Thu, August 27, 2020

Larry Biegelsen Maintained (ABT) at Buy with Increased Target to $115 on, Aug 27th, 2020


Published on 2024-10-27 12:42:47 - WOPRAI, Larry Biegelsen
  Print publication without navigation


Larry Biegelsen of Wells Fargo, Maintained "Abbott Laboratories" (ABT) at Buy with Increased Target from $107 to $115 on, Aug 27th, 2020.

Larry has made no other calls on ABT in the last 4 months.



There are 5 other peers that have a rating on ABT. Out of the 5 peers that are also analyzing ABT, 1 agrees with Larry's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Danielle Antalffy of "SVB Leerink" Maintained at Hold with Increased Target to $110 on, Friday, July 17th, 2020


These are the ratings of the 4 analyists that currently disagree with Larry


  • David Toung of "Argus Research" Maintained at Strong Buy with Increased Target to $125 on, Thursday, July 23rd, 2020
  • Joanne Wuensch of "Citigroup" Maintained at Strong Buy with Increased Target to $110 on, Friday, July 17th, 2020
  • John Sourbeer of "UBS" Maintained at Strong Buy with Increased Target to $110 on, Friday, July 17th, 2020
  • Matt Miksic of "Credit Suisse" Maintained at Buy with Increased Target to $109 on, Friday, July 17th, 2020